Clinical and laboratory changes induced by alpha interferon in chronic lymphocytic leukemia‐a pilot study

American Journal of Hematology

Volumn 24, Issue 4, 1987, Pages 341-350

  Talpaz, M ^a   Rosenblum, M ^a   Kurzrock, R ^a   Reuben, J ^a   Kantarjian, H ^a   Gutterman, J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

alpha interferon; CLL responses

Indexed keywords

ALPHA INTERFERON; AMSACRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; PREDNISONE; RECOMBINANT ALPHA INTERFERON A; RECOMBINANT ALPHA INTERFERON A S 35; UNCLASSIFIED DRUG; VINCRISTINE;

B LYMPHOCYTE; BLOOD AND HEMOPOIETIC SYSTEM; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHATIC LEUKEMIA; LYMPHATIC SYSTEM; PRIORITY JOURNAL; T LYMPHOCYTE; THERAPY;

2',5'-OLIGOADENYLATE SYNTHETASE; AGED; ANTIGENS, SURFACE; B-LYMPHOCYTES; ENZYME INDUCTION; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE I; ISOENZYMES; LEUKEMIA, LYMPHOCYTIC; LYMPHOCYTES; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, ANTIGEN, B-CELL;

EID: 0023235045     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.2830240403     Document Type: Article

References (21)

1. Induction of remission in hairy cell leukemia with alpha interferon
2. Chronic myelogenous leukemia: Hematologic remissions with alpha interferon
3. Collaborative phase I‐II study of recombinant DNA‐produced leukocyte interferon (Clone A) in metastatic breast cancer, malignant lymphoma, and multiple myeloma
4. Leukocyte interferon‐induced tumor regression in human metastatic breast cancer, multiple myeloma and malignant lymphoma
5. Follow‐up observations on the effect of human leukocyte interferon in non‐Hodgkin's lymphoma
6. Preliminary observations on the effect of human leukocyte interferon in non‐Hodgkin's lymphoma
7. Clinical staging of chronic lymphocytic leukemia
8. Synergistic antiviral and antiproliferative activities of E. coli derived human alpha, beta, and gamma interferons
9. Down regulation of peripheral blood cell interferon receptors in chronic myelogenous leukemia patients undergoing human interferon (HuIFN‐alpha) therapy
10. Metabolic stability of 2′, 5′ oligo A and activity of 2′, 5′ oligo A‐dependent endonuclease in extracts of interferon‐treated and control HeLa cells
11. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to α‐interferon: Correlation with receptor binding and induction of 2′ 5′ oligoadenylate synthetase
12. Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia
13. Recombinant leukocyte α‐interferon in B‐cell chronic lymphocytic leukemia: In vivo effects on autologous antitumor immunity
14. Treatment of lymphoid neoplasias with interferon. II. Human leucocyte α‐interferon in chronic lymphatic leukemia (CLL). Phase I‐II trial
15. Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non‐Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot Study
16. Surface markers in chronic lymphoid leukemias of B cell type
17. Surface immunoglobulin pattern of the leukaemic cell population in chronic lymphcytic leukemia (CLL) in relation to disease activity
18. Phase I trial of recombinant interferon gamma in cancer patients
19. Chronic B‐lymphocytic leukemia cells proliferate and differentiate following exposure to interferon in vitro
20. Regulation of human B‐cell activation, proliferation, and differentiation by soluble factors